Pharmacists Can Play Important Role in Depression Screening


The US Preventive Services Task Force recently updated its recommendations for depression screening in adults.

The US Preventive Services Task Force (USPSTF) recently updated its recommendations for depression screening in adults.

According to the USPSTF, major depressive disorder is the leading cause of disability among adults in high-income countries. When left untreated, depression can become chronic and refractory.

The USPSTF recommends that screening for depression can ultimately help reduce or eliminate depression symptoms, lower the need for related health care services, and improve the health of pregnant or postpartum patients with depression.

Risk factors for depression in pregnant or postpartum women, which are distinct from those associated with depression in other patient populations, include child-care stress, prenatal anxiety, single/unpartnered relationship status, difficult infant temperament, previous postpartum depression, and unintended pregnancy.

Although the USPSTF didn’t endorse a specific screening method, evidence from previous research suggests that pharmacists, as members of a collaborative care team, can play an important role in depression screening services.

One way in which pharmacists can contribute to depression screenings is to monitor patients taking medication regimens that may predispose them to depression symptoms. For example, research published in the February 2015 issue of Pain found that dispensing higher opioid doses to chronic pain patients could trigger depression.

Jeffery F. Scherrer, PhD, lead author of the Pain study, previously told Pharmacy Times that each pharmacy visit is an opportunity to educate the patient, and that pharmacists can “communicate in print or verbally that their patients should be aware of any changes in mood while taking their opioid analgesic.”

Beyond medication reviews, pharmacists’ accessibility may help patients who might otherwise avoid seeking help because of the social stigma of mental health issues. Pharmacists may be able to recognize symptoms of depression and other illnesses, and previous research has found that pharmacists trained with the proper skills and knowledge can identify and support patients with depression.

Of note, the USPSTF’s updated recommendations emphasize both newer-generation antidepressants and empirically supported psychotherapies either alone or in combination.

“If the clinicians working within a collaborative care model could rapidly incorporate the information that an initial prescription was not filled or was not refilled, it may be possible to diminish the chances that nonadherence will compromise treatment outcome,” postulated Michael E. Thase, MD, author of an editorial corresponding with the updated USPSTF recommendations.

The depression screening recommendations published online in the Journal of the American Medical Association on January 26, 2016, updates the task force’s 2009 and 2002 recommendations.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii |
Pharmacy Interior | Image Credit: Tyler Olson -
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi -
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen |
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/ |
Image credit: fidaolga -
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund |
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi -
© 2023 MJH Life Sciences

All rights reserved.